Director, Channel Operations Strategy, Advanced Platforms

This position is posted by Jobgether on behalf of a partner company. We are currently looking for a Director, Channel Operations Strategy, Advanced Platforms in United States.

This leadership role sits at the intersection of market access strategy, advanced therapy commercialization, and channel operations innovation. You will shape and execute operational models that enable the successful distribution, pricing, contracting, and field engagement strategies for complex therapies, including cell & gene, radioligand, and other advanced platform products. The role requires a strong blend of strategic thinking and hands-on execution in highly specialized pharmaceutical access environments. You will partner closely with cross-functional leaders across access, finance, trade, and commercial teams to ensure seamless launch and lifecycle execution. With direct impact on patient access and commercial performance, you will design scalable systems that support both innovation and operational excellence. This is a high-visibility role operating in a fast-evolving, science-driven environment where precision and collaboration are critical.

• Lead the design and execution of channel operations strategies supporting cell & gene therapy and radioligand therapy portfolios across distribution, dispensing, pricing, and contracting frameworks.
• Develop and implement operational models that enable effective market access field engagement, business-to-business interactions, and performance tracking across advanced platforms.
• Drive end-to-end contracting strategy execution, including negotiation, financial evaluation, and implementation of agreements with distribution partners, pharmacies, and GPOs.
• Align channel operations strategies with sales, marketing, medical, and market access stakeholders to ensure integrated execution and shared accountability.
• Build and enhance commercial data capabilities to support decision-making, field effectiveness, and channel performance optimization.
• Oversee monitoring systems and analytics to assess impact, improve access strategies, and enable continuous performance improvement across portfolios.
• Collaborate with finance, contracting, and trade operations teams to ensure compliance, operational efficiency, and successful implementation of channel programs.
• Provide strategic input on launch excellence, patient access strategies, and advanced therapy commercialization models.

Requirements

• Bachelor’s degree required; MBA or advanced degree preferred.
• 7+ years of experience in pharmaceutical industry, market access, consulting, pharmacy, or payer-focused roles.
• Strong understanding of U.S. healthcare economics, reimbursement systems, pricing, and pharmaceutical demand drivers.
• Extensive experience in healthcare contracting, distribution models, GPOs, and specialty pharmacy ecosystems.
• Proven ability to manage complex stakeholder environments and build relationships with executive-level partners.
• Strong analytical capabilities with experience in commercial data, field analytics, and performance measurement.
• Deep knowledge of pharmaceutical value chains, launch excellence, and market access strategy execution.
• Preferred: experience in cell & gene therapy, rare diseases, radioligand therapies, or other high-cost specialty products.
• Excellent negotiation, communication, and cross-functional leadership skills with strong strategic and operational judgment.

Benefits

• Competitive annual salary range: $194,600 – $361,400, with eligibility for performance-based bonuses and potential equity awards.
• Comprehensive health, dental, and vision insurance coverage.
• 401(k) retirement plan with company contribution and matching.
• Generous paid time off, including vacation, holidays, personal days, and additional leave programs.
• Life insurance, short-term and long-term disability coverage, and other wellbeing benefits.
• Flexible remote work model with up to 20% travel depending on business needs.
• Exposure to high-impact, cutting-edge therapeutic areas and large-scale commercial transformation initiatives.